THE CHOLANGIOCARCINOMA FOUNDATION
Programs
Cholangiocarcinoma Research Fellowships
RESEARCH THE CHOLANGIOCARCINOMA FOUNDATION CONTINUES TO FOCUS ON COLLABORATIVE RESEARCH EFFORTS WITH MEDICAL, SCIENTIFIC, ACADEMIC, REGULATORY, AND NOT- FOR-PROFIT PARTNERS. DURING THE YEAR ENDED JUNE 30, 2022, THE ORGANIZATION FUNDED ELEVEN FELLOWSHIPS FOR EARLY CAREER RESEARCHERS FOCUSING ON STUDIES IN CHOLANGIOCARCINOMA. THE ORGANIZATION FUNDED EFFORTS TO ENHANCE AND RESEARCH CHOLANGIOCARCINOMA GENETICS DATA. THE ORGANIZATION HAS ALSO CONTINUED THE SUPPORT OF A SPECIMEN REPOSITORY.GeographiesNot indicatedDatesJul 1, 2021 – Jun 30, 2022Source990No causes providedNo populations provided–$1.1MPatient Advocacy and Education Initiatives
ADVOCACY THE CHOLANGIOCARCINOMA FOUNDATION IS COMMITTED TO PROVIDING SERVICES TO PATIENTS AND THEIR FAMILIES AFFECTED BY THIS DEVASTATING DISEASE. BOTH PATIENTS AND THE PROFESSIONAL COMMUNITY ARE EDUCATED THROUGH THE ORGANIZATION'S ANNUAL CONFERENCE, WEBINARS, WEBSITE, AND BOOK 100 QUESTIONS AND ANSWERS ABOUT CHOLANGIOCARCINOMA. THE ORGANIZATION ALSO PROVIDES DISEASE EDUCATION, EMOTIONAL SUPPORT, AND MANY RESOURCES THROUGH ONLINE PATIENT SUPPORT GROUPS, SOCIAL MEDIA SITES, AND RESPONSES TO DAILY CALLS AND EMAILS. THROUGH INITIATIVES SUCH AS MUTATIONS MATTER, INTERNATIONAL PATIENT REGISTRY, ACTION ALERTS, AND THE BILIARY INFORMATION CARD, PATIENTS AND THEIR CAREGIVERS CAN PARTICIPATE IN RESEARCH EFFORTS WHILE BEING EMPOWERED TO TAKE PART IN THEIR HEALTHCARE. THE ORGANIZATION ALSO PARTNERS WITH LIKE-MINDED ORGANIZATIONS TO SPREAD AWARENESS ABOUT THE CHALLENGES FACED BY THE RARE DISEASE COMMUNITY.GeographiesNot indicatedDatesJul 1, 2021 – Jun 30, 2022Source990No causes providedNo populations provided–$1.7MProgram 1 [2025]
RESEARCH THE ORGANIZATION ADVANCES SCIENTIFIC DISCOVERY THROUGH ITS RESEARCH FELLOWSHIP PROGRAM, CAREER DEVELOPMENT AWARD, AND INNOVATION GRANTS, WHICH COLLECTIVELY SUPPORT EMERGING INVESTIGATORS AND FUND TRANSFORMATIVE, HIGH- IMPACT STUDIES. IT ALSO CONVENED THE INTERNATIONAL CHOLANGIOCARCINOMA CONSENSUS CONFERENCE, UNITING GLOBAL EXPERTS TO ESTABLISH RESEARCH PRIORITIES AND ACCELERATE CLINICAL TRANSLATION. THESE EFFORTS ARE ANCHORED IN THE INTERNATIONAL CHOLANGIOCARCINOMA RESEARCH NETWORK (ICRN) - A WORLDWIDE COLLABORATION DRIVING PROGRESS IN ETIOLOGY, PREVENTION, EARLY DETECTION, AND TREATMENT. THROUGH ICRN SUBCOMMITTEES, THE ORGANIZATION LEVERAGES SHARED DATA AND CULTIVATES FUTURE LEADERS IN RESEARCH AND CARE.GeographiesNot indicatedDatesJul 1, 2024 – Jun 30, 2025Source990No causes providedNo populations provided–$2M
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)